Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Survival in pulmonary arterial hypertension patients awaiting lung transplantation.

Gomberg-Maitland M, Glassner-Kolmin C, Watson S, Frantz R, Park M, Frost A, Benza RL, Torres F.

J Heart Lung Transplant. 2013 Dec;32(12):1179-86. doi: 10.1016/j.healun.2013.08.016.

PMID:
24074527
2.

Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era.

Schaffer JM, Singh SK, Joyce DL, Reitz BA, Robbins RC, Zamanian RT, Mallidi HR.

Circulation. 2013 Jun 25;127(25):2503-13. doi: 10.1161/CIRCULATIONAHA.112.001080.

3.

Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry.

Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, McGoon MD.

Transplantation. 2010 Aug 15;90(3):298-305. doi: 10.1097/TP.0b013e3181e49b83.

PMID:
20559158
4.

Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.

Thenappan T, Glassner C, Gomberg-Maitland M.

Chest. 2012 Mar;141(3):642-50. doi: 10.1378/chest.11-0969.

PMID:
21885728
5.

Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease.

Singh VK, Patricia George M, Gries CJ.

J Heart Lung Transplant. 2015 Mar;34(3):424-9. doi: 10.1016/j.healun.2015.01.002.

PMID:
25813769
6.

Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.

de Perrot M, Granton JT, McRae K, Pierre AF, Singer LG, Waddell TK, Keshavjee S.

J Thorac Cardiovasc Surg. 2012 Apr;143(4):910-8. doi: 10.1016/j.jtcvs.2011.08.055.

7.

Changes in pulmonary artery pressure affect survival differently in lung transplant recipients who have pulmonary hypertension or chronic obstructive pulmonary disease.

O'Keefe KL, Kilic A, Pope-Harman A, Hayes D Jr, Kirkby S, Higgins RS, Whitson BA.

Exp Clin Transplant. 2014 Aug;12(4):283-9.

8.
9.

Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Wille KM, Sharma NS, Kulkarni T, Lammi MR, Barney JB, Bellot SC, Cantor RS, Naftel DC, Diaz-Guzman E, McGiffin DC.

Ann Am Thorac Soc. 2014 Nov;11(9):1411-8. doi: 10.1513/AnnalsATS.201408-354OC.

PMID:
25296345
10.

Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension.

Chen H, Shiboski SC, Golden JA, Gould MK, Hays SR, Hoopes CW, De Marco T.

Am J Respir Crit Care Med. 2009 Sep 1;180(5):468-74. doi: 10.1164/rccm.200810-1603OC.

11.

Prognostic relevance of changes in exercise test variables in pulmonary arterial hypertension.

Groepenhoff H, Vonk-Noordegraaf A, van de Veerdonk MC, Boonstra A, Westerhof N, Bogaard HJ.

PLoS One. 2013 Sep 5;8(9):e72013. doi: 10.1371/journal.pone.0072013.

12.

An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension.

Eberlein M, Diehl E, Bolukbas S, Merlo CA, Reed RM.

J Heart Lung Transplant. 2013 Dec;32(12):1172-8. doi: 10.1016/j.healun.2013.06.011.

PMID:
23876630
13.

Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation.

de Perrot M, Granton JT, McRae K, Cypel M, Pierre A, Waddell TK, Yasufuku K, Hutcheon M, Chaparro C, Singer L, Keshavjee S.

J Heart Lung Transplant. 2011 Sep;30(9):997-1002. doi: 10.1016/j.healun.2011.03.002.

PMID:
21489818
14.

Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.

Douwes JM, Roofthooft MT, Bartelds B, Talsma MD, Hillege HL, Berger RM.

Int J Cardiol. 2013 Sep 30;168(2):1370-7. doi: 10.1016/j.ijcard.2012.12.080.

15.

Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score.

Gries CJ, Rue TC, Heagerty PJ, Edelman JD, Mulligan MS, Goss CH.

J Heart Lung Transplant. 2010 Jul;29(7):731-8. doi: 10.1016/j.healun.2010.02.007.

16.

Timing of single lung transplantation for primary pulmonary hypertension.

Nootens M, Freels S, Kaufmann E, Levy PS, Rich S.

J Heart Lung Transplant. 1994 Mar-Apr;13(2):276-81.

PMID:
8031812
17.

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.

Circulation. 2010 Jul 13;122(2):164-72. doi: 10.1161/CIRCULATIONAHA.109.898122.

18.

Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.

Hefke T, Zittermann A, Fuchs U, Schulte-Eistrup S, Gummert JF, Schulz U.

Thorac Cardiovasc Surg. 2012 Feb;60(1):26-34. doi: 10.1055/s-0030-1250726.

PMID:
21432755
19.
20.

Survival after lung transplantation in systemic sclerosis. A systematic review.

Khan IY, Singer LG, de Perrot M, Granton JT, Keshavjee S, Chau C, Kron A, Johnson SR.

Respir Med. 2013 Dec;107(12):2081-7. doi: 10.1016/j.rmed.2013.09.015. Review.

Supplemental Content

Support Center